Premier Health Reports 2026 First Quarter Results

Premier Health of America Inc. (TSX-V: PHA) (the "Company"), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended December 31, 2025.

⁽¹⁾  See the Company's MD&A for details on these non-GAAP measures.

Summary

• Adjusted EBITDA for the quarter was $5K ($0.7M for the same period last year), mainly driven by a decline in the British Columbia market.
• Net Loss for the quarter was $2.5M (loss of $2.3M for the same period last year).

The travel nurse and northern communities services are generally performing well, except in British Columbia, where the Company experienced a reduction in volume. This decline is attributable to a service acquisition centralization initiative undertaken by the health authorities, which is expected to ultimately favour the most competitive service providers such as SSI. During the quarter, the Company formally discontinued its Per Diem and Transportation operations, as these lines of business were no longer profitable, and has since focused its resources on its Travel Nurse operations across Canada.

"Our cost reduction plan is still progressing, and additional efforts were deployed in the current quarter. The Per Diem and transportation operations were abandoned this quarter, and our focus has fully shifted to Travel Nurses. In the short term, we remain committed to cost reduction, debt management, operational efficiency, and pursuing organic growth opportunities," said Guy D'Aoust, Interim CEO of Premier Health.

More information can be found in the Company's Quarterly Consolidated Financial Statements and MD&A as available on SEDAR+ at sedarplus.ca.

About Premier Health

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, companies, and individuals. Premier Health uses its proprietary LiPHe^® platform to lead the digital transformation of the healthcare services sector, providing patients with faster, more affordable, and more accessible care.

Non-GAAP Measures

Earnings before interest, taxes, depreciation, and amortization ("EBITDA"), is calculated as the net profit (loss), before non-recurring items excluding acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization, and depreciation), change in fair values, interest expense, and income tax expense (recovery). Adjusted EBITDA excludes Share-based compensation and unusual items, as determined from time to time. Gross margin is either used as a number or a percentage. As a number, it means Revenues minus Direct Costs. When used as a percentage, it means the ratio of Revenues minus Direct Costs to Revenues. More detail can be found in PHA's Management Discussion and Analysis.

For Further Information Please Contact:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This press release contains forward-looking information within the meaning of applicable securities legislation which reflects the current plans and expectations of the Company with respect to future events and financial performance. All statements other than statements of historical or current facts may be forward-looking information. Forward-looking information includes statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as ‘believes', ‘continues', ‘expects', ‘projects', ‘anticipates', ‘plans', ‘estimates', ‘seeks', ‘intends', ‘targets', ‘forecasts', or negative or grammatical versions thereof and other similar expressions, or future or conditional verbs such as ‘may', ‘will', ‘should', ‘would' and ‘could'. Forward-looking information in this press release includes, but is not limited to, statements with respect to the execution of the Company's growth strategy. Forward-looking information is based on management's plans, estimates, projections, beliefs and opinions as at the date of this release, and the assumptions related to those plans, estimates, projections, beliefs and opinions may change; therefore, they are presented for the purpose of assisting the Company's security holders in understanding management's views at such time regarding those future outcomes and may not be appropriate for other purposes. Although the forward-looking information contained in this release is based on assumptions which the Company believes are reasonable, there can be no assurance that actual results will be consistent with such forward-looking information. The forward-looking information in this release relate only to events or information as of the date on which the statements are made and, except as specifically required by applicable securities laws, the Company undertakes no obligation to update or revise publicly any forward-looking information, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. There can be no assurance that the forward-looking information will prove to be accurate. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Company with Canadian securities regulatory authorities available on SEDAR+ at www.sedarplus.ca